New combo therapy aims to extend lives in tough cancer recurrence
Disease control
Recruiting now
This study is for adults whose head and neck cancer has returned locally after previous radiation treatment. It compares two approaches: one group gets a repeat course of radiation with chemotherapy followed by immunotherapy (pembrolizumab), while the other gets the standard immu…
Phase: PHASE3 • Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC